126 related articles for article (PubMed ID: 22623106)
1. Saracatinib (AZD0530) is a potent modulator of ABCB1-mediated multidrug resistance in vitro and in vivo.
Liu KJ; He JH; Su XD; Sim HM; Xie JD; Chen XG; Wang F; Liang YJ; Singh S; Sodani K; Talele TT; Ambudkar SV; Chen ZS; Wu HY; Fu LW
Int J Cancer; 2013 Jan; 132(1):224-35. PubMed ID: 22623106
[TBL] [Abstract][Full Text] [Related]
2. Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo.
Yang K; Chen Y; To KK; Wang F; Li D; Chen L; Fu L
Exp Mol Med; 2017 Mar; 49(3):e303. PubMed ID: 28303028
[TBL] [Abstract][Full Text] [Related]
3. Essential oils from Inula japonica and Angelicae dahuricae enhance sensitivity of MCF-7/ADR breast cancer cells to doxorubicin via multiple mechanisms.
Wu M; Li T; Chen L; Peng S; Liao W; Bai R; Zhao X; Yang H; Wu C; Zeng H; Liu Y
J Ethnopharmacol; 2016 Mar; 180():18-27. PubMed ID: 26795076
[TBL] [Abstract][Full Text] [Related]
4. A dual PI3 kinase/mTOR inhibitor BEZ235 reverses doxorubicin resistance in ABCB1 overexpressing ovarian and pancreatic cancer cell lines.
Durrant DE; Das A; Dyer S; Kukreja RC
Biochim Biophys Acta Gen Subj; 2020 Jun; 1864(6):129556. PubMed ID: 32061787
[TBL] [Abstract][Full Text] [Related]
5. The SMAC mimetic GDC-0152 is a direct ABCB1-ATPase activity modulator and BIRC5 expression suppressor in cancer cells.
Lin IL; Lin YT; Chang YC; Kondapuram SK; Lin KH; Chen PC; Kuo CY; Coumar MS; Cheung CHA
Toxicol Appl Pharmacol; 2024 Apr; 485():116888. PubMed ID: 38452945
[TBL] [Abstract][Full Text] [Related]
6. Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor.
Yang Y; Ji N; Cai CY; Wang JQ; Lei ZN; Teng QX; Wu ZX; Cui Q; Pan Y; Chen ZS
Cancer Commun (Lond); 2020 Jul; 40(7):285-300. PubMed ID: 32525624
[TBL] [Abstract][Full Text] [Related]
7. Mosloflavone from Fissistigma petelotii ameliorates oncogenic multidrug resistance by STAT3 signaling modulation and P-glycoprotein blockade.
Chien PY; Lan YH; Wu IT; Huang YP; Hung CC
Phytomedicine; 2024 Jan; 123():155210. PubMed ID: 38006807
[TBL] [Abstract][Full Text] [Related]
8. Bruton's Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells.
Dong XD; Zhang M; Ma X; Wang JQ; Lei ZN; Teng QX; Li YD; Lin L; Feng W; Chen ZS
Front Cell Dev Biol; 2020; 8():865. PubMed ID: 32984343
[TBL] [Abstract][Full Text] [Related]
9. Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer.
McCorkle JR; Gorski JW; Liu J; Riggs MB; McDowell AB; Lin N; Wang C; Ueland FR; Kolesar JM
PLoS One; 2021; 16(8):e0254205. PubMed ID: 34347777
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and bioactivity study on oxygen-heterocyclic-based pyran analogues as effective P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell.
Abd El-Wahab AHF; Borik RMA; Al-Dies AM; Fouda AM; Mohamed HM; El-Eisawy RA; Mora A; El-Nassag MAA; Abd Elhady AM; Elhenawy AA; El-Agrody AM
Sci Rep; 2024 Mar; 14(1):7589. PubMed ID: 38555345
[TBL] [Abstract][Full Text] [Related]
11. Reversal of Multidrug Resistance in Human Colon Cancer and Human Leukemia Cells by Three Plant Extracts and Their Major Secondary Metabolites.
Zhou JX; Wink M
Medicines (Basel); 2018 Nov; 5(4):. PubMed ID: 30428619
[No Abstract] [Full Text] [Related]
12. Comparative study on ABCB1-dependent efflux of anthracyclines and their metabolites: consequences for cancer resistance.
Piska K; Koczurkiewicz-Adamczyk P; Jamrozik M; Bucki A; Kołaczkowski M; Pękala E
Xenobiotica; 2023 Dec; 53(6-7):507-514. PubMed ID: 37753851
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin-induced compartmentalisation of doxorubicin sharpens up nuclear topoisomerase II inhibition in human rhabdomyosarcoma cells.
Werner M; Atil B; Sieczkowski E; Chiba P; Hohenegger M
Naunyn Schmiedebergs Arch Pharmacol; 2013 Jul; 386(7):605-17. PubMed ID: 23564041
[TBL] [Abstract][Full Text] [Related]
14. The epigallocatechin gallate derivative Y
Wen Y; Zhao R; Gupta P; Fan Y; Zhang Y; Huang Z; Li X; Su Y; Liao L; Xie YA; Yang D; Chen ZS; Liang G
Acta Pharm Sin B; 2019 Mar; 9(2):316-323. PubMed ID: 30972279
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug Resistance.
Luo X; Teng QX; Dong JY; Yang DH; Wang M; Dessie W; Qin JJ; Lei ZN; Wang JQ; Qin Z; Chen ZS
Front Pharmacol; 2020; 11():1208. PubMed ID: 32903706
[TBL] [Abstract][Full Text] [Related]
16. Andrographolide reverts multidrug resistance in KBCh
Lakra DS; Bharathiraja P; Dhanalakshmi T; Prasad NR
Cell Biochem Funct; 2024 Mar; 42(2):e3948. PubMed ID: 38379216
[TBL] [Abstract][Full Text] [Related]
17. Dual Drug Repurposing: The Example of Saracatinib.
Ramos R; Vale N
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674150
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of ABCB1 confers resistance to FLT3 inhibitor FN-1501 in cancer cells: in vitro and in vivo characterization.
Zhang M; Huang MN; Dong XD; Cui QB; Yan Y; She ML; Feng WG; Zhao XS; Wang DT
Am J Cancer Res; 2023; 13(12):6026-6037. PubMed ID: 38187048
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic adaptations in OXPHOS power output and reduced tumorigenicity characterize doxorubicin resistant ovarian cancer cells.
Hagen JT; Montgomery MM; Biagioni EM; Krassovskaia P; Jevtovic F; Shookster D; Sharma U; Tung K; Broskey NT; May L; Huang H; Brault JJ; Neufer PD; Cabot MC; Fisher-Wellman KH
Biochim Biophys Acta Bioenerg; 2022 Nov; 1863(8):148915. PubMed ID: 36058252
[TBL] [Abstract][Full Text] [Related]
20. Elevated ABCB1 Expression Confers Acquired Resistance to Aurora Kinase Inhibitor GSK-1070916 in Cancer Cells.
Wu ZX; Yang Y; Wang JQ; Zhou WM; Chen J; Fu YG; Patel K; Chen ZS; Zhang JY
Front Pharmacol; 2020; 11():615824. PubMed ID: 33519482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
